Correlation Between Manhattan Associates and Enfusion

Can any of the company-specific risk be diversified away by investing in both Manhattan Associates and Enfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Manhattan Associates and Enfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Manhattan Associates and Enfusion, you can compare the effects of market volatilities on Manhattan Associates and Enfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Manhattan Associates with a short position of Enfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Manhattan Associates and Enfusion.

Diversification Opportunities for Manhattan Associates and Enfusion

-0.65

Correlation Coefficient

Manhattan Associates  Enfusion

Excellent diversification

The 3 months correlation between Manhattan and Enfusion is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Manhattan Associates and Enfusion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enfusion and Manhattan Associates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Manhattan Associates are associated (or correlated) with Enfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enfusion has no effect on the direction of Manhattan Associates i.e., Manhattan Associates and Enfusion go up and down completely randomly.

Pair Corralation between Manhattan Associates and Enfusion

Given the investment horizon of 90 days Manhattan Associates is expected to under-perform the Enfusion. In addition to that, Manhattan Associates is 2.42 times more volatile than Enfusion. It trades about -0.16 of its total potential returns per unit of risk. Enfusion is currently generating about 0.07 per unit of volatility. If you would invest  1,047  in Enfusion on December 30, 2024 and sell it today you would earn a total of  63.00  from holding Enfusion or generate 6.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Manhattan Associates  vs.  Enfusion

Manhattan Associates

Risk-Adjusted Performance

Very Weak

Over the last 90 days Manhattan Associates has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Enfusion

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Enfusion are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Enfusion may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Manhattan Associates and Enfusion

The main advantage of trading using opposite Manhattan Associates and Enfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Manhattan Associates position performs unexpectedly, Enfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enfusion will offset losses from the drop in Enfusion's long position.

The idea behind Manhattan Associates and Enfusion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.